Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Symptom management of COVID-19 positive patients in an acute NHS trust: a specialist palliative care team perspective

James Renshaw, Ruth Caulkin, Sarah Cox, Dijay Dave and Lisa McAleny
Download PDF
DOI: https://doi.org/10.7861/clinmed.21-2-s15
Clin Med March 2021
James Renshaw
AChelsea and Westminster Hospital, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth Caulkin
AChelsea and Westminster Hospital, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Cox
AChelsea and Westminster Hospital, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dijay Dave
AChelsea and Westminster Hospital, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa McAleny
AChelsea and Westminster Hospital, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Introduction

Despite a 33% mortality rate for hospital admissions with COVID-19, data around end-of-life care needs in the context of the virus remain lacking.1 We present a study of 89 COVID-19 hospital patients who received specialist palliative care team (SPC) input. This study delivers a novel understanding of the symptom needs of those dying from COVID-19, with recommendations for generalist management of these patients.

Materials and methods

The electronic patient records of 89 COVID-19 positive patients with SPC involvement in an acute trust during a 1-month period (20 March 2020 – 21 April 2020) were reviewed retrospectively. Patients were managed at ward level, some with non-invasive ventilation (NIV); intensive care unit patients were excluded. Patients were followed up at the end of April. Data were analysed using MS Excel.

Results and discussion

Eighty-four per cent (n=75) of COVID-19 positive patients had died at follow-up (median SPC involvement time of 2 days (interquartile range (IQR) 1–5)).

The most frequent symptoms in patients dying from COVID-19 were breathlessness (92%; n=69), pyrexia (44%; n=33) and agitation (45%; n=34). COVID-19 positive patients commonly required symptom control medications (84%; n=63) and continuous subcutaneous infusions (CSCIs; 69%; n=52), reinforcing our clinical experience of a highly symptomatic dying phase. Symptoms and trajectories were too unstable for transdermal medication use.

Symptoms were managed with low doses of opioid and benzodiazepine medications (Fig 1), with a median CSCI morphine equivalent dose of 15 mg (range 5–60; IQR 10–20; n=51) and median CSCI midazolam dose of 10 mg (range 5–60; IQR 10–20; n=40).

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

Medical management of end-of-life symptoms in COVID-19.

Patients' high symptom burden and rapidity of deterioration did not always allow typical practice of using as needed (PRN) medications for a 24-hour period prior to CSCI initiation. The early use of CSCIs was therefore essential to ensure symptom control, and access to medications given staffing pressures. This was reflected in the low median amounts of subcutaneous morphine and midazolam required in the 24 hours preceding a CSCI (morphine median 2.75 mg (IQR 2.5–7.5) and midazolam 2.5 mg (IQR 2.5–5)). A high percentage of alfentanil use in CSCIs (37%; n=19) was observed, possibly reflecting micro-embolic-driven renal impairment in COVID-19.2 Only 23% (n=17) of patients required opioid dose escalation and 17% (n=12) required midazolam dose escalation, again reinforcing the ability to manage symptoms with low doses of medications. Few patients required glycopyrronium (n=15) and antiemetics (n=5) via a CSCI.

Thirty-three per cent (n=4) of COVID-19 positive patients who survived required symptom control medication, with 17% (n=2) requiring CSCIs; our experience was that some patients required CSCI's to enable them to tolerate medical management, such as NIV.

Conclusion

Those dying from COVID-19 often have a rapid deterioration and symptomatic dying phase, making early symptom control paramount. Symptom control can be achieved with traditional drugs often at low doses, though with earlier use of CSCIs. Effective symptom management may also improve response to active medical treatments, such as tolerance of NIV. Education and reassurance for generalists (Fig 2) in the early use of opioids and benzodiazepines is essential to managing symptoms of patients with COVID-19.

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

Recommendations for generalist symptom management in COVID-19.

Conflicts of interest

None declared.

  • © Royal College of Physicians 2021. All rights reserved.

References

  1. ↵
    1. Doherty A
    , Harrison EM, Green CA, et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. medRxiv 2020.04.23.20076042.
  2. ↵
    1. Ronco C
    , Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med 2020;8:738–42.
    OpenUrl
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Symptom management of COVID-19 positive patients in an acute NHS trust: a specialist palliative care team perspective
James Renshaw, Ruth Caulkin, Sarah Cox, Dijay Dave, Lisa McAleny
Clinical Medicine Mar 2021, 21 (Suppl 2) 15-16; DOI: 10.7861/clinmed.21-2-s15

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Symptom management of COVID-19 positive patients in an acute NHS trust: a specialist palliative care team perspective
James Renshaw, Ruth Caulkin, Sarah Cox, Dijay Dave, Lisa McAleny
Clinical Medicine Mar 2021, 21 (Suppl 2) 15-16; DOI: 10.7861/clinmed.21-2-s15
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Materials and methods
    • Results and discussion
    • Conclusion
    • Conflicts of interest
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Macklin effect in COVID-19
  • Acute management of suspected vaccine induced thrombocytopenia and thrombosis
  • Pneumothorax and pneumomediastinum in COVID-19
Show more COVID-19

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians